Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin + Ciclofosfamide + Fluorouracil + Paclitaxel|DRUG: Epirubicin + Cisplatin + Fluorouracil|DRUG: Docetaxel + Ciclofosfamide
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla